News

Filter

Current filters:

Abarelix

1 to 9 of 31 results

GlaxoSmithKline makes niche acquisition with $54.8 million bid for Praecis

22-12-2006

UK-headquartered pharmaceutical major GlaxoSmithKline has entered into a definitive agreement to acquire…

AbarelixAmino AcidsDrug DiscoveryGlaxoSmithKlineGSKInjectionPhysostigmine SalicylatePlenaxisSchering Ag

Praecis cuts workforce 60% in reshuffle

30-05-2005

USA-based biopharmaceutical firm Praecis Pharmaceuticals has unveiled cost-cutting restructuring measures,…

AbarelixDrug DiscoveryNystatinOralPlenaxis

Praecis and Schering AG sign Plenaxis accord

03-05-2004

USA-based Praecis Pharmaceuticals has entered into a license, supply and distribution agreement with…

AbarelixPlenaxisSchering Ag

FDA clears Praecis' prostate cancer drug

08-12-2003

The US Food and Drug Administration has granted marketing authorizationto Praecis Pharmaceuticals for…

AbarelixAmgenPlenaxis

Praecis updates on Plenaxis status

05-08-2002

Praecis Pharmaceuticals of the USA has updated the status of itsPlenaxis (abarelix) prostate cancer program,…

AbarelixPlenaxis

Praecis' Plenaxis effective in endometriosis

01-07-2002

Praecis Pharmaceuticals has reported preliminary results from a PhaseII/III trial of Plenaxis (abarelix)…

AbarelixAmino AcidsInjectionLeuprolide Acetate InjectionLupronPhysostigmine SalicylatePlenaxis

1 to 9 of 31 results

Back to top